Eversheds Sutherland has advised Ingevity Corporation on its €590m acquisition of Warrington-based Perstorp UK Limited, the caprolactone division of the wider Perstorp Group. The transaction, which…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
